title: Is a SUV cut-off necessary in the evaluation of the response of axillary lymph node metastases to neoadjuvant therapy?
authors.forename: Laura
authors.initials: L
authors.lastname: Gilardi
authors.forename: Giovanni
authors.initials: G
authors.lastname: Paganelli
mesh_terms: D001692:Biological Transport; D001943:Breast Neoplasms / Q000175:diagnosis / Q000378:metabolism / Q000473:pathology* / Q000628:therapy*; D019788:Fluorodeoxyglucose F18 / Q000378:metabolism; D006801:Humans; D008207:Lymphatic Metastasis; D020360:Neoadjuvant Therapy; D049268:Positron-Emission Tomography; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D019788:Fluorodeoxyglucose F18
references.citation: J Clin Oncol. 2005 Apr 20;23(12):2694-702
references.pmid: 15837984
references.citation: J Nucl Med. 2009 May;50 Suppl 1:55S-63S
references.pmid: 19380410
references.citation: Eur J Nucl Med Mol Imaging. 2010 Jun;37(6):1069-76
references.pmid: 20130860
references.citation: Eur J Nucl Med Mol Imaging. 2010 Oct;37(10):1834-41
references.pmid: 20533032